semaglutide and prostate cancer ESMO 2024: Targeting Epigenetic Pathways semaglutide prostate cancer In high-risk

4jl and Supplementary Fig

10.3390/cancers15153959 18 BoseK.ScurtF

First it was Ozempic butt, but now, over in America, Hershey says one unexpected group is helping drive sales of gum and mints: people taking GLP-1 weight loss drugs

These can include health risks from counterfeit or compounded medication, disreputable companies offering GLP-1 medication at very low prices, or from unsafe sources

In fact, lipoprotein(a) is so strongly linked to heart disease, that it is one of the four lipid-related risk factors cited by the National Institutes of Health National Cholesterol Education Program (NCEP) as worthy of monitoring